Saturday, July 19, 2025 7/19/2025

Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers

Award Number: R01CA231952
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/07/2019
PERIOD OF PERFORMANCE END DATE: 11/30/2025

Group Awards By:

View Award Description

Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers - SUMMARY Efficiently connecting underserved smokers with limited resources to efficacious tobacco cessation treatments that are easily accessible is crucial for disease prevention and the elimination of health disparities. This study seeks to address this need through partnering with a large social service network to evaluate the efficacy and economic impact of a theoretically-based, fully automated, interactive smartphone-based smoking cessation intervention. The Regional Food Bank of Oklahoma (RFBO) is the largest hunger-relief charity in the state, and through a network of 14 Food and Resource Centers (FRC), provides food to more than 136,000 food insecure clients each week across 53 counties. Our preliminary data indicate that the prevalence of current smoking among adult clients is 46% (more than 3 times the prevalence in the general US population). Participants (n=500) will be randomized to one of two treatment conditions: 1) Standard Treatment (ST; n=250) or Automated Treatment (AT; n=250). ST participants will be electronically connected to the Oklahoma Tobacco Helpline using a tablet-based web portal that is specific to this study. This approach is designed to mirror the Ask Advise Connect (AAC) approach to linking smokers in healthcare systems with quitline treatment that our team has previously developed and evaluated. ST will be evaluated against AT, a fully automated treatment enrollment and delivery approach. In the AT condition, participants will receive an interactive smartphone- based intervention that comprises content delivered via audio/video clips and interactive text content. Much of the programming and developmental work for AT has already been completed by the Stephenson Cancer Center's mHealth Shared Resource, and results from a series of pilot studies (including work conducted in partnership with the RFBO sites) with beta versions of the mobile application are extremely encouraging. Nicotine replacement therapy (NRT) in the form of transdermal patches will be provided to all participants (ST and AT). Our overall goal of this project is to determine if AT performs better than the more resource intensive ST approach. If efficacy is established, the AT approach will be readily scalable, easily implemented by community-based organizations, and offer an efficient way to allocate limited public health resources to tobacco control interventions. The primary aim is to evaluate the efficacy of AT and ST in facilitating abstinence from smoking. It is hypothesized that at the 12-month follow-up assessment, 7-day point prevalence smoking abstinence rates will be higher in AT compared to ST. Secondary aims are to: 1) Compare the magnitude of the mediated effects via common mechanisms (i.e., motivation, agency, and stress/negative affect) on smoking abstinence between the AT and ST treatment groups; and 2) Conduct economic evaluations to assess the cost and/or cost-effectiveness of AT vs. ST. There is a critical need for theoretically-based, cost-effective, and sustainable cessation treatments that have broad dissemination potential, and the AT intervention has been designed to help fill this need.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2024	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 USF MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	000	6	12/6/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $530,773 )
2024	2024	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 USF MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	001	6	4/17/2024	NON-COMPETING CONTINUATION	$27,936
2024	2024	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	000	6	11/9/2023	NON-COMPETING CONTINUATION	$502,837
														Subtotal = $530,773

Issue Date FY: 2023 ( Subtotal = $589,303 )
2023	2023	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	001	5	3/20/2023	NON-COMPETING CONTINUATION	$48,107
2023	2023	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	000	5	12/1/2022	NON-COMPETING CONTINUATION	$541,196
														Subtotal = $589,303

Issue Date FY: 2022 ( Subtotal = $593,495 )
2022	2022	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	000	4	11/8/2021	NON-COMPETING CONTINUATION	$545,047
2022	2022	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	001	4	5/31/2022	NON-COMPETING CONTINUATION	$48,448
														Subtotal = $593,495

Issue Date FY: 2021 ( Subtotal = $602,423 )
2021	2021	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	002	3	11/3/2020	NON-COMPETING CONTINUATION	$572,302
2021	2021	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	003	3	1/22/2021	NON-COMPETING CONTINUATION	$30,121
2021	2019	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	001	2	10/26/2020	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$0
2021	2019	UNIVERSITY OF OKLAHOMA	865 RESEARCH PKWY STE 530	OKLAHOMA CITY	OK	73104	OKLAHOMA	USA	Cancer Cause and Prevention Research	000	1	10/26/2020	NEW	$0
														Subtotal = $602,423

Issue Date FY: 2020 ( Subtotal = $57,470 )
2020	2019	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	001	2	1/22/2020	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$521,823
2020	2019	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	003	2	4/1/2020	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$57,470
2020	2019	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	005	2	9/4/2020	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	-$28,407
2020	2019	UNIVERSITY OF OKLAHOMA	865 RESEARCH PKWY STE 530	OKLAHOMA CITY	OK	73104	OKLAHOMA	USA	Cancer Cause and Prevention Research	004	1	9/4/2020	NEW	$28,407
2020	2019	H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE HOSPITAL, INC.	12902 MAGNOLIA DR	TAMPA	FL	33612	HILLSBOROUGH	USA	Cancer Cause and Prevention Research	002	2	3/4/2020	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$0
2020	2019	UNIVERSITY OF OKLAHOMA	865 RESEARCH PKWY STE 530	OKLAHOMA CITY	OK	73104	OKLAHOMA	USA	Cancer Cause and Prevention Research	000	1	1/22/2020	NEW	-$521,823
														Subtotal = $57,470

Issue Date FY: 2019 ( Subtotal = $539,162 )
2019	2019	UNIVERSITY OF OKLAHOMA	865 RESEARCH PKWY STE 530	OKLAHOMA CITY	OK	73104	OKLAHOMA	USA	Cancer Cause and Prevention Research	000	1	4/19/2019	NEW	$552,473
2019	2019	UNIVERSITY OF OKLAHOMA	865 RESEARCH PKWY STE 530	OKLAHOMA CITY	OK	73104	OKLAHOMA	USA	Cancer Cause and Prevention Research	001	1	7/4/2019	NEW	-$13,311
														Subtotal = $539,162

Grand Total All Awards = $2,912,626

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers

Award Number: R01CA231952

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/07/2019

PERIOD OF PERFORMANCE END DATE: 11/30/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer